β-catenin-IN-2 (Compound H1B1) is a small-molecule inhibitor of β-catenin intended for preclinical research, particularly studies of colorectal cancer and Wnt/β-catenin signaling. The compound is characterized by CAS 1458664-10-2, molecular formula C15H14FN3, molecular weight 255.29, and is supplied with analytical documentation for research use.
- Potent β-catenin inhibitor suitable for cellular and biochemical assays.
- Reported applicability in colorectal cancer research.
- High purity (99.6%) for reliable experimental results.
- Characterized with COA, HNMR, and LCMS data available.
- Small-molecule properties: molecular weight 255.29, formula C15H14FN3.